Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • November 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Advanced Micro Incision Glaucoma Surgery (istent) For the First Time in India at Shree Ramkrishna Netralaya, Thane, Mumbai and Navi Mumbai
    Business

    Advanced Micro Incision Glaucoma Surgery (istent) For the First Time in India at Shree Ramkrishna Netralaya, Thane, Mumbai and Navi Mumbai

    By October 22, 2021No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Mumbai (Maharashtra) [India], October 22: Shree Ramkrishna Netralaya is pleased to bring istent, and istent inject by Glaukos, the USA for the first time in India. This is the world’s smallest medical device known to be implanted in the human body.

    Glaucoma, a sneak thief of sight that Affects 3 in every 100 people across the globe. Glaucoma genes are passed from one generation to another. These altered genes change the constitution of the trabecular meshwork, an area in the front part of the eye through which fluid inside the eye can flow out. This causes blockage of water (aqueous humor) inside the eye, which leads to raised pressure inside the eye, causing damage to the optic nerve.

    Dr. Nitin Deshpande of Shree Ramkrishna Netralaya, on the occasion of launch functions, said, “Glaucoma being the 3rd largest cause of blindness in India, with almost 12 million diagnosed patients, we in Shree Ramakrishna Eye Hospital, is committed towards adopting the latest innovation in the field of glaucoma, to ensure world-class patient management and preserving vision till death.”

    He further said that “iStent & iStent inject, the latest global innovation by Glaukos Corporation, USA, has been implanted in 3 patients for the first time in India, in our institute. It’s a micro-invasive glaucoma surgery procedure, which not only helps in managing glaucoma effectively and safely but also helps in fighting the key issue of non-adherence to current medication (eye drops), the key reason for glaucoma progression in 53% of treated patients. Since glaucoma is asymptomatic, the damage is already advanced once the patient realizes that he has visual problems.

    Once this device is entangled in trabecular meshwork by a skilled surgeon, it increases the outflow of eye fluid (aqueous Humor) which restores the balance of pressure inside the eye, preventing further damage to the Optic Nerve.”

    There are multiple advantages to this new generation of glaucoma surgery:

    • It can be inserted through micro-incision, there is minimal injury to the eye
    • This device can be implanted during routine cataract surgery, preventing the need for additional cuts
    • The use of surgical grade titanium and a proven track record makes this surgery safe for the eye.

    Shree Ramkrishna Netralaya is a recipient of the prestigious full NABH accredited eye institute in Thane, Mulund and Navi Mumbai. Its well-equipped glaucoma department is providing world-class Glaucoma care at an affordable cost for over 15 years. We are committed to providing compassionate eye care to all under one roof.

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Duroply Showcases its Built-to-Last Legacy

    November 14, 2026

    Austere Systems Announces H1 FY27 Results

    November 14, 2026

    ROX Hi-Tech Announces Unaudited Financial Results for H1 FY27

    November 14, 2026

    Comments are closed.

    Recent Post
    • Duroply Showcases its Built-to-Last Legacy
    • Austere Systems Announces H1 FY27 Results
    • ROX Hi-Tech Announces Unaudited Financial Results for H1 FY27
    • PAN HR Solution Limited Reports H1 FY27 Results
    • Why Colonialism Still Matters: Museum of British Colonialism to Host Online Panel Discussion on 19 November
    • Dr. R. K. Thukral and the Work of Bringing Neuropsychiatry Closer to Patients
    • From Global Recognition to Academic Excellence: LBSIM’s Continuing Journey After AACSB Accreditation
    • DEV Information Technology Reports Q2 FY27 Total Income of Rs. 63.07 Cr, Up 28 Percent YoY; H1 FY27 Total Income Reaches Rs. 107.72 Cr, Up 16 Percent YoY

    Type above and press Enter to search. Press Esc to cancel.